<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04107857</url>
  </required_header>
  <id_info>
    <org_study_id>89276</org_study_id>
    <secondary_id>P30CA091842</secondary_id>
    <nct_id>NCT04107857</nct_id>
  </id_info>
  <brief_title>Electronic Health Record-Enabled Evidence-Based Smoking Cessation Quality Improvement Implementation Program</brief_title>
  <official_title>Electronic Health Record-Enabled Evidence-based Smoking Cessation Quality Improvement Program</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this quality improvement program is to implement, evaluate, and sustain an
      evidence-based smoking cessation treatment program with a population-based approach so that
      all patients at the Siteman Cancer Center, Washington University, Barnes-Jewish Hospital, BJC
      Healthcare, and satellite locations receive assessment of smoking and all smokers receive
      treatment support.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 2, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 2, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinic level percentage of patients receiving brief counseling</measure>
    <time_frame>From 6 months pre-intervention through 6 months post-intervention</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinic level percentage of smokers offered referral to additional counseling</measure>
    <time_frame>From 6 months pre-intervention through 6 months post-intervention</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinic level percentage of smokers offered medication</measure>
    <time_frame>From 6 months pre-intervention through 6 months post-intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinic level percentage of patients receiving brief counseling</measure>
    <time_frame>Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinic level percentage of smokers offered referral to additional counseling</measure>
    <time_frame>Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinic level percentage of smokers offered medication</measure>
    <time_frame>Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinic level percentage of smokers receiving smoking assessment</measure>
    <time_frame>Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinic level percentage of smokers receiving cessation medication</measure>
    <time_frame>Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients who have abstained from smoking</measure>
    <time_frame>Estimated to be 6 months post-intervention</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000000</enrollment>
  <condition>Smoking Cessation</condition>
  <arm_group>
    <arm_group_label>Smoking Cessation</arm_group_label>
    <description>Patients enter the program through clinic appointments or community outreach programs.
Patients will be given brief advice to quit smoking and referral options to receive evidence-based treatment through Missouri/Illinois Quitlines, Smokefree.TXT, or smokefree.gov dependent on the patient's preference for counseling
Patient can also be prescribed smoking cessation pharmacotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>ELEVATE enhancement to electronic health record (EHR) to improve cessation counseling offer</intervention_name>
    <description>Brief advise to quit smoking
Referral to Missouri/Illinois Quitlines, Smokefree.TXT, or smokefree.gov</description>
    <arm_group_label>Smoking Cessation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>ELEVATE enhancement to electronic health record (EHR) to improve smoking cessation medication offer</intervention_name>
    <description>-Nicotine replacement therapy, varenicline, bupropion, or combination therapy (not provided by study)</description>
    <arm_group_label>Smoking Cessation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Data Driven Feedback reports</intervention_name>
    <description>-Feedback reports will be based on data</description>
    <arm_group_label>Smoking Cessation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients 18 years of age or older
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -Patients seen at Siteman Cancer Center, Washington University, Barnes-Jewish Hospital, BJC
        Healthcare, or any of the satellite locations

        Exclusion Criteria:

        -None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Li-Shiun Chen, M.D., ScD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Li-Shiun Chen, M.D., ScD, MPH</last_name>
    <phone>314-362-3932</phone>
    <email>li-shiun@wustl.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nina Smock</last_name>
    <phone>314-362-1854</phone>
    <email>smockn@wustl.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Li-Shiun Chen, M.D., ScD, MPH</last_name>
    </contact>
    <contact_backup>
      <last_name>Nina Smock</last_name>
      <phone>314-362-1854</phone>
      <email>smockn@wustl.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Li-Shiun Chen, M.D., ScD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.siteman.wustl.edu</url>
    <description>Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine</description>
  </link>
  <link>
    <url>https://siteman.wustl.edu/prevention/smoking-cessation-program/</url>
    <description>Related Info</description>
  </link>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>September 25, 2019</study_first_submitted>
  <study_first_submitted_qc>September 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 27, 2019</study_first_posted>
  <last_update_submitted>December 5, 2019</last_update_submitted>
  <last_update_submitted_qc>December 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

